Literature DB >> 27327014

Perioperative support reduces mortality of obese BALB/c mice after ovariectomy.

Laura Mattheis1, Juliane-Susanne Jung1, Bernhard Hiebl2, Wiebke Garrels3, Heike Kielstein1, Julia Spielmann1.   

Abstract

The incidence of obesity is on the rise in most western countries and represents major risks to health. Obesity causes complex metabolic dysfunctions and can be associated with a large number of secondary diseases. To investigate causal mechanisms of obesity and develop better options for treatment, researchers study the condition in animal models. In addition to genetically engineered animal models, diet-induced obesity is often used because it occurs similarly in animals as it does in humans. For several types of investigations that use obesity models, investigators must carry out surgical interventions and they frequently encounter severe perioperative complications induced by anesthesia. In an example of this problem, we observed 100% mortality in obese BALB/c mice after ovariectomy, despite no obvious surgical complications. We supposed that a failure to recover from surgery was the primary cause of this increased mortality. Therefore, to support their recovery from surgery we administered atropine to obese mice in order to facilitate blood circulation, and we also increased the oxygen content of the ambient air. With this specific support before and after surgery, we increased the survival rate of obese ovariectomized mice up to 83%. These results confirm the assumption that obesity is a risk factor for the recovery of obese animal models after ovariectomy, and they highlight the need to provide additional interventions for such experimental animals.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27327014     DOI: 10.1038/laban.1042

Source DB:  PubMed          Journal:  Lab Anim (NY)        ISSN: 0093-7355            Impact factor:   12.625


  32 in total

Review 1.  Preanaesthetic use of atropine in small animals.

Authors:  K A Brock
Journal:  Aust Vet J       Date:  2001-01       Impact factor: 1.281

Review 2.  The impact of obesity on the pharmacology of medications used for cardiovascular risk factor control.

Authors:  Sowndramalingam Sankaralingam; Richard B Kim; Raj S Padwal
Journal:  Can J Cardiol       Date:  2014-10-28       Impact factor: 5.223

3.  Results of the confidential enquiry into perioperative small animal fatalities regarding risk factors for anesthetic-related death in dogs.

Authors:  David C Brodbelt; Dirk U Pfeiffer; Lesley E Young; James L N Wood
Journal:  J Am Vet Med Assoc       Date:  2008-10-01       Impact factor: 1.936

4.  Weight change and risk of postmenopausal breast cancer (United States).

Authors:  A Trentham-Dietz; P A Newcomb; K M Egan; L Titus-Ernstoff; J A Baron; B E Storer; M Stampfer; W C Willett
Journal:  Cancer Causes Control       Date:  2000-07       Impact factor: 2.506

5.  Pharmacokinetics of ketamine and xylazine in young and old Sprague-Dawley rats.

Authors:  Daphnée Veilleux-Lemieux; Aude Castel; Denise Carrier; Francis Beaudry; Pascal Vachon
Journal:  J Am Assoc Lab Anim Sci       Date:  2013-09       Impact factor: 1.232

Review 6.  A review of the physiological effects of alpha2-agonists related to the clinical use of medetomidine in small animal practice.

Authors:  Melissa D Sinclair
Journal:  Can Vet J       Date:  2003-11       Impact factor: 1.008

7.  Patient selection for day case-eligible surgery: identifying those at high risk for major complications.

Authors:  Michael R Mathis; Norah N Naughton; Amy M Shanks; Robert E Freundlich; Christopher J Pannucci; Yijia Chu; Jason Haus; Michelle Morris; Sachin Kheterpal
Journal:  Anesthesiology       Date:  2013-12       Impact factor: 7.892

Review 8.  Effect of obesity on the pharmacokinetics of drugs in humans.

Authors:  Michael J Hanley; Darrell R Abernethy; David J Greenblatt
Journal:  Clin Pharmacokinet       Date:  2010       Impact factor: 6.447

9.  A comparison of medetomidine and its active enantiomer dexmedetomidine when administered with ketamine in mice.

Authors:  Wesley M Burnside; Paul A Flecknell; Angus I Cameron; Aurélie A Thomas
Journal:  BMC Vet Res       Date:  2013-03-13       Impact factor: 2.741

Review 10.  Adipokines - removing road blocks to obesity and diabetes therapy.

Authors:  Matthias Blüher
Journal:  Mol Metab       Date:  2014-01-21       Impact factor: 7.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.